TCBIO
Get informed when a big investor buys or sells
+ FollowUndervalued by 841% based on the discounted cash flow analysis.
| Market cap | $4.34 Billion |
|---|---|
| Enterprise Value | $2.52 Billion |
| Dividend Yield | $1.44 (-) |
| Earnings per Share | $6.87 |
| Beta | 0.69 |
| Outstanding Shares | 45,021,962 |
| P/E Ratio | 12.55 |
|---|---|
| PEG | 22.08 |
| Price to Sales | 0.52 |
| Price to Book Ratio | 0.26 |
| Enterprise Value to Revenue | 1.38 |
| Enterprise Value to EBIT | 4.62 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 0.24 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data